Skip to main content

Nasdaq News

Regeneron's Libtayo Wins EMA CHMP Support For Extended Dosing

1 day 17 hours ago
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of an alternative dosing schedule for Libtayo (cemiplimab) acr
RTTNews
Checked
12 minutes 35 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed